PNAS 1998, 95: 6349–6354 PubMedCrossRef 6 Wang RF, Liu M, Zhang

PNAS 1998, 95: 6349–6354.PubMedCrossRef 6. Wang RF, Liu M, Zhang CL, Guo FQ, Zhao GY: Experimental study on tumor cell apoptosis imaging in vivo

with 99m Tc-HYNIC-Annexin V in tumor-bearing mice. Chin J Med Imaging Technol 2005, 11: 1663–1666. 7. Kartachova M, Haasb RL, Olmosa RA, Hoebersb FJ, Zandwijkc Nv, Verheijb M: In vivo imaging of apoptosis PI3K Inhibitor Library high throughput by 99m Tc-Annexin V scintigraphy:visual analysis in relation to treatment response. Radiother Oncol 2004, 72: 333–339.PubMedCrossRef 8. Haas RL, Jong D, Olmos RA, Hoefnagel CA, Heuvel ID, Zerp SF, Bartelink H, Verheij M: In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients. Int J Radiat Oncol Biol Phys 2004, 59: 782–787.PubMedCrossRef Mocetinostat in vitro 9. Larsen SK, Solomon HF, Caldwell G, Abrams MJ: [ 99m Tc] tricine: a useful precursor complex for the radiolabeling of hydrazinonicotinate protein conjugates. Bioconju Chem 1995, 6: 635–638.CrossRef 10. Verbeke K, Kieffer D, Vanderheyden JL, Reutelingsperger

C, Steinmetz ND, Green AM, Verbruggen A: Optimization of the preparation of (99m) Tc-labeled Hynic-derivatized Annexin V for human use. Nucl Med Biol 2003, 30: 771–778.PubMedCrossRef 11. Mochizuki T, Kuge Y, Zhao Sj, Tsukamoto E, Hosokawa M, Strauss HW, Blankenberg FG, Tait JF, Tamaki N: Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99m Tc-Annexin V. J Nucl Med 2003, 44: 92–97.PubMed 12. Wong E, Kumar V, Howman-Giles RB, Vanderheyden JL: Imaging of Therapy-Induced Apoptosis Using 99m Tc-HYNIC-Annexin V in Thymoma Tumor-Bearing Mice. Cancer Biother Radiopharm 2008, 23: 715–725.PubMedCrossRef 13. Hammill AK, Uhr JW, Scheuermann RH: Annexin V staining

due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death. Exp Cell Res 1999, 251: 16–21.PubMedCrossRef 14. Martin S, Pombo I, Poncet P, David B, Arock M, Blank Adenosine U: Immunologic stimulation of mast cells leads to the reversible exposure of phosphatidylserine in the absence of apoptosis. Int Arch Allergy Immunol 2000, 123: 249–258.PubMedCrossRef 15. Geske FJ, Monks J, Lehman L, Fadok VA: The role of the macrophage in apoptosis: hunter, gatherer, and regulator. Int J Hematol 2002, 76: 16–26.PubMedCrossRef 16. Yang DJ, Azhdarinia A, Wu P, Yu DF, Tansey W, Kalimi SK, Kim EE, Podoloff DA: In vivo and in vitro measurement of apoptosis in breast cancer cells using 99m Tc-EC-annexin V. Cancer Biother Radiopharm 2001, 16: 73–83.PubMedCrossRef 17. Liu ZZ, Huang WY, Li XS, Lin JS, Cai XK, Lian KH, Zhou HJ: Prediction value of radiosensitivity of hepatocarcinoma cells for apoptosis and micronucleus assay. World J Gastroenterol 2005, 11: 7036–7039.PubMed 18. Sheridan MT, West CM: Ability to undergo apoptosis dose not correlate with the intrinsic radiosensitivity (SF2) of human cervix tumor cell lines.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>